| LEC # | TOPICS | INSTRUCTORS |
|---|---|---|
| 1 |
General introduction "Genome-wide association studies for complex traits: consensus, uncertainty and challenges." Reading assignment handed out |
|
| 2 | Bipolar disorder | Roy H. Perlis (MD, Harvard Medical School, MA) |
| 3 | Psychosis, Schizophrenia |
Dost Ongur (MD, PhD, McLean Hospital, MA) Bruce Cohen (MD, PhD, McLean Hospital, MA) |
| 4 | Genetics of psychiatric disorder | Pamela Sklar (MD, PhD, Mass General Hospital, MA Harvard Medical School, MA) |
| 5 | DISC1 | Li-Huei Tsai (PhD, MIT, MA) |
| 6 | Ca++ signaling | Michael Greenberg (PhD, Harvard Medical School, MA) |
| 7 | Literature discussion: neurogenesis and depression | Lead by Simona Tescu (MIT, MA) and Aline Blunk (MIT, MA) |
| 8 | Lithium and GSK3 hypothesis | Steve Haggarty (PhD, Harvard Medical School, MA) |
| 9 |
Behavioral assays "Overview of animal models of Schizophrenia." Reading assignment handed out "Different behaviors and different strains: potential new ways to model bipolar disorder." Reading assignment handed out "The ascent of mouse: advances in modelling human depression and anxiety." Reading assignment handed out |
Tracey Petryshen (PhD, MIT, MA) |
| 10 |
CREB in addiction and depressive behaviors "Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis." Reading assignment handed out "Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules." Reading assignment handed out "The mesolimbic dopamine reward circuit in depression." Reading assignment handed out |
Bill Carlezon (PhD, McLean Hospital, MA) |
| 11 | Literature discussion: the GABA System-I | Lead by Stuart Layton (MIT, MA) and Matt Ogdie (MIT, MA) |
| 12 | Literature discussion: the GABA System-II | |
| 13 | Literature discussion: the glutamate hypothesis of Schizophrenia | Lead by Takahiro Soda (Harvard Medical School, MA) and Carol Watkins (MD, PhD, Northern County Psychiatric Associates, MD) |
| 14 | Literature discussion: the dopamine pathway and DARPP32 | Lead by Takahiro Soda (Harvard Medical School, MA) and Nadya Modyanova (PhD, MIT, MA) |








